Agomab Therapeutics announces shareholder meetings

• Agomab will hold a Special General Meeting in Antwerp, Belgium on Sept. 11, 2026.
• Shareholders will vote on proposed appointments of Marino Garcia and Naimish Patel, M.D., as non-executive board members.
• An Extraordinary General Shareholders’ Meeting will also be held in Antwerp, Belgium on Sept. 11, 2026.
• Vote planned on consolidating and splitting outstanding pre-IPO warrants to reflect the share split tied to the February 2026 IPO.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agomab Therapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608101607PRIMZONEFULLFEED1001256949) on August 10, 2026, and is solely responsible for the information contained therein.